We have changed our name from Cure Our Ovarian Cancer to the Ovarian Cancer Foundation NZ » Read More

Formerly Cure Our Ovarian Cancer > Read more

Support low-grade serous ovarian cancer in the united kingdom

The Low-Grade Serous Ovarian Cancer Initiative has proudly partnered with the University of Edinburgh since 2018 to fund Professor Charlie Gourley and Dr Robb Hollis’ low-grade serous ovarian cancer (LGSOC) research.

Through our joint efforts in fundraising and donations, we can significantly advance knowledge and progress treatments for LGSOC. As the University of Edinburgh has a broader focus than just ovarian cancer, we encourage you to direct your donations or fundraising through the links on this page to ensure that your support benefits the LGSOC-specific research fund.

Professor Charlie Gourley and Dr Robb Hollis’ research

Medical oncologist Professor Charlie Gourley and scientist Dr. Robb Hollis are leading efforts in the United Kingdom to improve survival rates for low-grade serous ovarian cancer. Their research focuses on understanding gene and molecular changes in LGSOC, to discover new and enhanced treatments.

Funds raised through the LGSOC Initiative have allowed them to recruit a researcher to develop sophisticated 3-dimensional LGSOC cancer models in the laboratory, known as organoids.

Fundraise or donate today to help us fund transformational LGSOC research!

LGSOC hero: Catherine Noonan

Catherine Noonan of Limerick, Ireland, was diagnosed with stage IV low-grade serous ovarian cancer in 2021 at the age of 42.

Catherine hopes that additional research will lead to a longer life expectancy, allowing her to be here for her kids.

Catherine has raised over €25,000 to support Professor Gourely’s research into LGSOC – and hasn’t stopped yet!

I was very active and healthy, however, looking back I did have the signs.

I’m extremely grateful for my life and don’t take things for granted anymore. I want to make people more aware that ovarian cancer can happen to anyone… it needs funding and research.

Catherine